David Rescott
Stock Analyst at Robert W. Baird
(3.54)
# 2,215
Out of 4,478 analysts
247
Total ratings
47.7%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiated Coverage: Buy | $121 | $95.63 | +26.53% | 1 | Jun 30, 2026 | |
| MDT Medtronic | Maintained: Hold | $100 → $85 | $83.06 | +2.34% | 24 | Jun 4, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $75 → $70 | $44.60 | +56.95% | 28 | May 28, 2026 | |
| HAE Haemonetics | Maintained: Buy | $81 → $67 | $75.02 | -10.69% | 6 | May 8, 2026 | |
| LIVN LivaNova | Maintained: Buy | $83 → $76 | $84.03 | -9.56% | 23 | May 7, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $168 → $140 | $71.23 | +96.55% | 7 | May 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $74 → $50 | $49.45 | +1.11% | 19 | May 5, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $104 → $83 | $71.45 | +16.17% | 13 | May 1, 2026 | |
| RMD ResMed | Maintained: Hold | $281 → $225 | $218.40 | +3.02% | 9 | May 1, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $200 → $175 | $126.03 | +38.86% | 30 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $28 | $21.21 | +32.01% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 | $95.18 | -8.59% | 22 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $655 → $610 | $432.83 | +40.93% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.72 → $4.62 | $1.77 | +161.02% | 8 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $345 → $374 | $318.23 | +17.53% | 26 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $116.30 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $26 | $17.68 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $89.76 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $20.45 | n/a | 1 | Dec 21, 2021 |
Abbott Laboratories
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $121
Current: $95.63
Upside: +26.53%
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $100 → $85
Current: $83.06
Upside: +2.34%
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $75 → $70
Current: $44.60
Upside: +56.95%
Haemonetics
May 8, 2026
Maintained: Buy
Price Target: $81 → $67
Current: $75.02
Upside: -10.69%
LivaNova
May 7, 2026
Maintained: Buy
Price Target: $83 → $76
Current: $84.03
Upside: -9.56%
TransMedics Group
May 6, 2026
Maintained: Buy
Price Target: $168 → $140
Current: $71.23
Upside: +96.55%
Inspire Medical Systems
May 5, 2026
Maintained: Hold
Price Target: $74 → $50
Current: $49.45
Upside: +1.11%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $104 → $83
Current: $71.45
Upside: +16.17%
ResMed
May 1, 2026
Maintained: Hold
Price Target: $281 → $225
Current: $218.40
Upside: +3.02%
iRhythm Holdings
May 1, 2026
Maintained: Buy
Price Target: $200 → $175
Current: $126.03
Upside: +38.86%
Apr 30, 2026
Maintained: Hold
Price Target: $30 → $28
Current: $21.21
Upside: +32.01%
Apr 24, 2026
Maintained: Hold
Price Target: $87
Current: $95.18
Upside: -8.59%
Apr 22, 2026
Maintained: Buy
Price Target: $655 → $610
Current: $432.83
Upside: +40.93%
Mar 23, 2026
Maintained: Hold
Price Target: $5.72 → $4.62
Current: $1.77
Upside: +161.02%
Jan 15, 2026
Downgraded: Hold
Price Target: $345 → $374
Current: $318.23
Upside: +17.53%
Apr 24, 2025
Maintained: Hold
Price Target: n/a
Current: $116.30
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $17 → $26
Current: $17.68
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $145
Current: $89.76
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $75
Current: $20.45
Upside: n/a